Dr. Andrew A. Hicks is Deputy Scientific Director and Group Leader for Neuromedicine at the Center for Biomedicine (CBM) at the European Academy in Bolzano (EURAC), where he has worked since 2007. Hicks received his BA and MA degrees in Biochemistry with supplemental Chemical Pharmacology from the University of Oxford in 1985 and received his PhD in Molecular Neurobiology in 1989 from the University of Cambridge, working at the MRC Molecular Neurobiology Unit based at the Laboratory of Molecular Biology site. Following a 2 year position as Senior Research Associate for Neurosciences at Peterhouse, Cambridge, he moved to a post of Project Leader in the CNRS laboratory of Jacques Mallet in Paris. In 1998 he took a position in industry as Project Leader at deCODE genetics Inc. in Iceland where he stayed until 2007. As Deputy Scientific Director at the CBM his role is to set and execute science strategy aimed at building up a sustainable biomedical research center for the region, in addition to coordinating use of CBM resources in many of the outreach research activities that the Center is involved in. He has a wide overview of the myriad cardiovascular, neurological and metabolic research projects currently using CBM data, and is continually strengthening existing, and seeking novel, academic and industrial partnerships in order to maximize use of the research resources being generated through research at the Center. Hicks’s primary role as Group Leader of the Neuromedicine group within the Center for Biomedicine is to promote the use of molecular genotyping and phenotyping platforms to support population- and case-oriented research into some of the pressing neurological and neuropsychiatric issues facing society. He has currently over 16,300 citations from 134 papers (H=47).
Neuroscience; Movement, Sleep, Pain and Psychiatric disorders; Healthy ageing; Population genetics.